Superparamagnetic iron oxide as a tracer for sentinel node biopsy in breast cancer: A comparative non-inferiority study.

AIMS: The gold standard for detection of Sentinel Lymph Nodes (SLN) is a combined radioisotope and blue dye breast injection, using a gamma probe (GP). A new, non-radioactive method was developed, using a tracer (Sienna+(®)) of superparamagnetic iron oxide (SPIO) nanoparticles and a manual magnetometer (SentiMag(®)) (SM). The IMAGINE study was designed to show the non-inferiority of SM compared to GP, for the detection of SLN in breast cancer patients with SLN biopsy indication. METHODS: From November 2013 to June 2014, 181 patients were recruited, and 321 nodes were excised and assessed ex-vivo. Readings from both SM and GP devices were recorded during transcutaneous, intraoperative, and ex-vivo detection attempts. RESULTS: At the patient level, ex-vivo detection rates (primary variable) with SM and GP were 97.8% and 98.3% (concordance rate 99.4%). Transcutaneous and intraoperative detection rates were 95.5% vs 97.2%, and 97.2% vs 97.8% for SM and GP respectively (concordance rates > 97%). At the node level, intraoperative and ex-vivo detection rates were 92.5% vs 89.3% and 91.0% vs 86.3% for SM and GP respectively. In all cases the non-inferiority of SM compared to SM was shown by ruling out a predefined non-inferiority margin of 5%. CONCLUSIONS: Our study showed the non-inferiority of SM as compared to GP. Moreover, the ex-vivo and intraoperative detection rates at the node level were slightly higher with SM.

[Chylous fistula following lymphadenectomy in breast cancer]. / Fístula quilosa tras linfadenectomía axilar en cáncer de mama.

Axillary lymph node dissection remains an integral part of surgical treatment in patients with invasive breast cancer and axillary lymph node metastases. Chylous leakage after axillary lymph node dissection is infrequent. We report the case of a patient with an advanced local breast cancer that was subsidiary to surgery treatment after neoadjuvant chemotherapy. She had a postoperative chylous leakage; it was successfully treated conservatively in the postoperative course. Chylous leakage an infrequent complication alters axillary lymph node dissection, which has a conservative management in most published studies.

[Radiofrequency ablation of breast carcinomas: preliminary results of a clinical trial]. / Ablación por radiofrecuencia de carcinomas de mama: resultados preliminares de un ensayo clínico.

OBJECTIVE: Among the alternatives to breast conserving surgery in breast cancer, radiofrequency ablation is the most widespread. We aimed to determine the feasibility, safety, and efficacy of this technique in our environment. MATERIAL AND METHODS: We performed radiofrequency ablation of breast carcinomas under local anesthesia in the ultrasonography examination room. We included 35 patients (mean age=61.2+/-8.25 years) with invasive carcinomas measuring less than 2cm (mean diameter=8.9+/-2.9mm) and located far from the skin and chest wall. Prior to radiofrequency treatment, all patients underwent core biopsy to confirm that the tumors were invasive carcinomas and selective lymphadenectomy. Carcinomas were excised 2 to 4 weeks after radiofrequency treatment and analyzed histologically to evaluate the effects of radiofrequency treatment on the tumor and surrounding tissue. The degree of coagulation necrosis and involvement of the margins was evaluated using hematoxylin and eosin staining. Cellular viability or effectiveness of the radiofrequency treatment was evaluated using NADH diaphorase. RESULTS: In total, 85.7% of patients reported no discomfort; 11.4% reported mild, controllable pain. Intense pain required the procedure to be discontinued in one patient. No other complications occurred. Signs of coagulation necrosis were observed in all cases; coagulation necrosis was classified as complete in 32/35 (91.4%). NADH diaphorase was negative in 27 of the 32 cases in which it was performed; one case was slightly positive and the other four were impossible to evaluate. CONCLUSION: Radiofrequency ablation of breast carcinomas is feasible, well tolerated, safe, and efficacious in nearly 90% of invasive tumors. The efficacy of the technique should be confirmed through extended follow-up of patients without subsequent surgical intervention in carefully designed and monitored phase III trials.

[Biopsy techniques for the diagnosis of non-palpable mammary lesions]. / Técnicas de biopsia para el diagnóstico de lesiones mamarias no palpables.

Facing a non-palpable mammary lesion requiring a diagnostic biopsy, consideration must be given to the most suitable guiding method for obtaining the latter. Three methods are employed at present: stereotaxy (basically in cases of microcalcifications), echography (above all in the nodules), and magnetic resonance (for lesions not made visible through the previous systems). The next step is to select the most suitable biopsy technique. The most classical and reliable technique is the surgical biopsy with prior marking using a metallic harpoon, but, besides its high cost, it has the drawback of being an aggressive technique for the diagnosis of a benign pathology. Numerous systems of puncture have been developed as alternatives. Puncture with a fine needle is technically simple to carry out and can provide good results in the mammary nodules, but the existence of positive and negative false results has progressively limited its use. As an alternative, the systems of biopsy with a broad needle have made it possible to obtain multiple cylinders with a high diagnostic reliability, above all in the case of mammary nodules. However, their use in microcalcifications continues to show negative false results. The arrival of systems of vacuum-assisted biopsy has made it possible to obtain cylinders of greater quality, above all in cases of microcalcifications. Finally, the systems of percutaneous resection biopsy by means of cannulas with a diameter of 22 mm make it possible to completely extract lesions of a size below that of the cannula, with a reliability similar to that of the surgical biopsy.

[Early detection of breast cancer in Navarra. Diagnostic approach in women sent to a referral hospital]. / Detección precoz del cáncer de mama en Navarra. Conducta diagnóstica en las mujeres enviadas a un hospital de referencia.

BACKGROUND: Breast cancer screening programs represent an important increase in the number of patients to be evaluated and a higher proportion of subclinical lesions detected in reference hospitals. The authors' experience related to an early detection program initiated in Navarra, Spain (PDPCM) is herein presented. METHODS: The diagnoses made in 319 women referred from the PDPCM to the authors' hospital for mammographic suspicion of malignancy were reviewed. Directed surgical biopsy was carried out in 89 women (27.9%) without previous cytologic study. Fine needle aspiration punction and cytology (FNAP-cytology) were performed as the first diagnostic test in 216 lesions (67.7%) 53 of which were palpable and 163 nonpalpable. Aggressive techniques were not indicated in 14 cases (4.4%). RESULTS: A total of 136 carcinomas (42.6%) were diagnosed and benign lesions were find at biopsy in 112 (35.1%) women. The fifty-seven lesions (17.9%) which did not show malignancy on FNAP-cytology were not biopsied given the insufficient degree of suspicion. Only one false negative has appeared in this group from 27 to 48 months after the first consultation. The global diagnostic reliability was of 99.68%. CONCLUSIONS: Directed surgical biopsy is the most reliable technique for the diagnosis of nonpalpable breast lesions in early stages and is always necessary when there is medium or high radiologic suspicion of malignancy. Fine needle aspiration puncture is a very useful technique to confirm malignancy and to avoid unnecessary biopsies in low suspicion lesions.